YAZ®

DRUG3 trials

Sponsors

Teva Pharmaceuticals USA, Boehringer Ingelheim

Conditions

Healthy

Phase 1

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

CompletedNCT01182207

Teva Pharmaceuticals USAHealthy

Start: 2006-07-31End: 2006-08-31Updated: 2010-12-08

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

CompletedNCT01182194

Teva Pharmaceuticals USAHealthy

Start: 2006-06-30End: 2006-08-31Updated: 2010-12-08

A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood

SuspendedNCT07656792

Boehringer IngelheimHealthy

Start: 2026-07-17End: 2026-11-26Target: 36Updated: 2026-08-19